Open AccessThis article is
- freely available
Chemotherapeutic Interventions Against Tuberculosis
Department of Laboratory Medicine and Pathology, 728-Heritage Medical Research Center, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2S2, Canada
Department of Pharmacy, Mangalayatan University, Beswan, Aligarh 202 145, India
Department of Surgery, 728-Heritage Medical Research Center, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2S2, Canada
* Author to whom correspondence should be addressed.
Received: 15 May 2012; in revised form: 12 June 2012 / Accepted: 21 June 2012 / Published: 28 June 2012
Abstract: Tuberculosis is the second leading cause of infectious deaths globally. Many effective conventional antimycobacterial drugs have been available, however, emergence of multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) has overshadowed the effectiveness of the current first and second line drugs. Further, currently available agents are complicated by serious side effects, drug interactions and long-term administration. This has prompted urgent research efforts in the discovery and development of new anti-tuberculosis agent(s). Several families of compounds are currently being explored for the treatment of tuberculosis. This review article presents an account of the existing chemotherapeutics and highlights the therapeutic potential of emerging molecules that are at different stages of development for the management of tuberculosis disease.
Keywords: tuberculosis chemotherapy; mycobacterium; drug-resistant tuberculosis; emerging TB drugs
Citations to this Article
Cite This Article
MDPI and ACS Style
Shakya, N.; Garg, G.; Agrawal, B.; Kumar, R. Chemotherapeutic Interventions Against Tuberculosis. Pharmaceuticals 2012, 5, 690-718.
Shakya N, Garg G, Agrawal B, Kumar R. Chemotherapeutic Interventions Against Tuberculosis. Pharmaceuticals. 2012; 5(7):690-718.
Shakya, Neeraj; Garg, Gaurav; Agrawal, Babita; Kumar, Rakesh. 2012. "Chemotherapeutic Interventions Against Tuberculosis." Pharmaceuticals 5, no. 7: 690-718.